Decitabine API Market, Global Outlook and Forecast 2023-2030
Decitabine is a?cytosine?analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes. Decitabine is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated in causing clinically apparent liver injury with jaundice.
This report aims to provide a comprehensive presentation of the global market for Decitabine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decitabine API. This report contains market size and forecasts of Decitabine API in global, including the following market information:
Global Decitabine API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Decitabine API Market Sales, 2018-2023, 2024-2030, (Ton)
Global top five Decitabine API companies in 2022 (%)
The global Decitabine API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity?98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Decitabine API include Dr. Reddy?s Laboratories Ltd., Biophore India Pharmaceuticals, Tecoland Corporation, Johnson Matthey PLC, Farmhispania, S.A., VShilpa Medicare Limitedbshilpa, Wuhan Calmland Pharmaceuticals Co.,Ltd, ScinoPharm Taiwan, Ltd and Zhejiang Hisun Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Decitabine API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Decitabine API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Decitabine API Market Segment Percentages, by Type, 2022 (%)
Purity?98%
Purity<98%
Global Decitabine API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Decitabine API Market Segment Percentages, by Application, 2022 (%)
Decitabine Injections
Others
Global Decitabine API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Decitabine API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Decitabine API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Decitabine API revenues share in global market, 2022 (%)
Key companies Decitabine API sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Decitabine API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy?s Laboratories Ltd.
Biophore India Pharmaceuticals
Tecoland Corporation
Johnson Matthey PLC
Farmhispania, S.A.
VShilpa Medicare Limitedbshilpa
Wuhan Calmland Pharmaceuticals Co.,Ltd
ScinoPharm Taiwan, Ltd
Zhejiang Hisun Pharmaceutical
Mac-Chem Products (India) Pvt.Ltd
Synthland Limited
Hanways Chempharm Co., Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Decitabine API, market overview.
Chapter 2: Global Decitabine API market size in revenue and volume.
Chapter 3: Detailed analysis of Decitabine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Decitabine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Decitabine API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
